Naperville, IL -- (SBWIRE) -- 09/28/2012 -- Actis Biologics, Inc - Product Pipeline Review - 2012 provides data on the Actis Biologics, Inc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
- Actis Biologics, Inc - Brief Actis Biologics, Inc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Actis Biologics, Inc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Actis Biologics, Inc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Actis Biologics, Inc’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Actis Biologics, Inc’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Actis Biologics, Inc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Actis Biologics, Inc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Actis Biologics, Inc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Actis Biologics, Inc and identify potential opportunities in those areas.
Current R&D Portfolio of Actis Biologics, Inc; Actis Biologics, Inc - Key Therapeutics; Actis Biologics, Inc - Pipeline Overview and Promising Molecules; Actis Biologics, Inc - News; Actis Biologics, Inc - Latest Updates; Actis Biologics, Inc - Pipeline; Actis Biologics, Inc - Discontinued/Dormant Projects
To view table of contents for this market report please visit:
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)